Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials-Reference-Cited by-同舟云学术

Efficacy of carboplatin–taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials

Published:2010-02 Issue:2 Volume:21 Page:312-318
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Regan M.M.,O'Donnell E.K.,Kelly W.K.,Halabi S.,Berry W.,Urakami S.,Kikuno N.,Oh W.K.

Funder

Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE

CALGB Statistical Center to S.H.

CALGB Participating Center to W.K.O.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/2/312/925553/mdp308.pdf

Reference26 articles.

1. Cancer statistics, 2003;Jemal;CA Cancer J Clin,2003

2. Hormone-refractory prostate cancer: a multi-step and multi-event process;De La Taille;Prostate Cancer Prostatic Dis,2001

3. Docetaxel and estramustine compared to mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

4. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

5. A critical analysis of response criteria in patients with prostatic cancer treated with cis-diamminedichloride platinum II;Yagoda;Cancer,1979

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs;Research and Reports in Urology;2023-06

2. Cancer stem cell in prostate cancer progression, metastasis and therapy resistance;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-05

3. Metastatic Castration-Resistant Prostate Cancer: Insights on Current Therapy and Promising Experimental Drugs;RES REP UROL;2023

4. The role of carboplatin in combination with paclitaxel in patients with castration-resistant prostate cancer;Future Oncology;2022-12

5. Genetics of neuroendocrine prostate cancer: recent progress in genetic understanding is translating into therapeutic opportunities;Current Opinion in Urology;2022-07-15